Stay updated on Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T03:57:10.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A notice announces changes to NIH websites and says that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    0.8%
    Check dated 2026-10-25T05:00:44.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T04:41:59.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer now displays website revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T08:09:59.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry for v3.7.0 and the previous revision v3.6.6 is removed from the history.
    Difference
    0.1%
    Check dated 2026-09-20T02:39:26.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The history log now includes a new revision label v3.6.6, replacing the previous v3.6.5. This reflects an update to the page's revision in the study record history.
    Difference
    0.1%
    Check dated 2026-08-29T19:50:19.000Z thumbnail image

Stay in the know with updates to Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.